Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Dimerization of FGFR4 mutants with enhanced kinase activity

Class:IdReaction:2038946
_displayNameDimerization of FGFR4 mutants with enhanced kinase activity
_doReleaseTRUE
_timestamp2014-12-03 20:54:31
authored[InstanceEdit:2105031] Rothfels, K, 2012-02-09
compartment[Compartment:876] plasma membrane
created[InstanceEdit:2038947] Rothfels, K, 2012-01-10
disease[Disease:1500689] cancer
[Disease:1614291] rhabdomyosarcoma
edited[InstanceEdit:2252592] Rothfels, K, 2012-05-16
entityFunctionalStatus[EntityFunctionalStatus:5654496] gain_of_function of FGFR4 enhanced kinase mutants [plasma membrane]
input[CandidateSet:2038948] FGFR4 enhanced kinase mutants [plasma membrane] [Homo sapiens]
[CandidateSet:2038948] FGFR4 enhanced kinase mutants [plasma membrane] [Homo sapiens]
isChimericFALSE
literatureReference[LiteratureReference:2038923] Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
modified[InstanceEdit:2046375] Rothfels, K, 2012-01-11
[InstanceEdit:2105613] Rothfels, K, 2012-02-10
[InstanceEdit:2123544] Rothfels, K, 2012-02-14
[InstanceEdit:2156382] Rothfels, K, 2012-02-28
[InstanceEdit:2248846] Rothfels, K, 2012-05-15
[InstanceEdit:2275109] Rothfels, K, 2012-05-25
[InstanceEdit:5654495] Rothfels, Karen, 2014-12-03
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameDimerization of FGFR4 mutants with enhanced kinase activity
normalReaction
output[CandidateSet:2038942] FGFR4 enhanced kinase mutant dimers [plasma membrane] [Homo sapiens]
releaseDate2012-06-12
reviewed[InstanceEdit:2248845] Ezzat, S, 2012-05-15
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:2294920] R-HSA-2038946.2
summation[Summation:2046364] FGFR4 is highly expressed in rhabdomyosarcoma (RMS) tissue, ...
(hasEvent)[Pathway:1839128] FGFR4 mutant receptor activation [Homo sapiens]
(precedingEvent)[Reaction:2038944] Autocatalytic phosphorylation of FGFR4 mutants with enhanced kinase activity [Homo sapiens]
[Reaction:2046363] FGFR4 kinase mutants are inhibited by PD170734 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Dimerization of FGFR4 mutants with enhanced kinase activity (2038946)